In 2012, Zheng et al. identified LILRB2 as the receptor for ANGPTL2 and ANGPTL5, demonstrating that signaling through this receptor maintains hematopoietic stem cell (HSC) stemness and promotes leukemia development 70. Here, LILRB2 is linked to leukemia.